Susquehanna International Group’s InflaRx IFRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$69K Buy
77,114
+37,741
+96% +$35.7K ﹤0.01% 12520
2025
Q4
$39.8K Sell
39,373
-102,682
-72% -$128K ﹤0.01% 11824
2025
Q3
$190K Buy
+142,055
New +$151K ﹤0.01% 11046
2025
Q1
Sell
-20,842
Closed -$51.5K 12918
2024
Q4
$51.5K Buy
20,842
+8,468
+68% +$16.3K ﹤0.01% 11661
2024
Q3
$18.9K Buy
+12,374
New +$18.8K ﹤0.01% 11635
2024
Q1
Sell
-16,966
Closed -$27.7K 12687
2023
Q4
$27.7K Sell
16,966
-20,125
-54% -$34.5K ﹤0.01% 11896
2023
Q3
$111K Sell
37,091
-141,153
-79% -$537K ﹤0.01% 10837
2023
Q2
$795K Buy
178,244
+71,149
+66% +$319K ﹤0.01% 7208
2023
Q1
$208K Buy
107,095
+78,575
+276% +$170K ﹤0.01% 10516
2022
Q4
$88.4K Sell
28,520
-19,658
-41% -$50.1K ﹤0.01% 11065
2022
Q3
$127K Buy
48,178
+1,428
+3% +$3.22K ﹤0.01% 11455
2022
Q2
$68K Buy
+46,750
New +$71K ﹤0.01% 11785
2022
Q1
Sell
-27,414
Closed -$130K 13446
2021
Q4
$130K Sell
27,414
-10,103
-27% -$40.6K ﹤0.01% 11951
2021
Q3
$97K Buy
37,517
+3,853
+11% +$10.1K ﹤0.01% 12091
2021
Q2
$100K Sell
33,664
-25,807
-43% -$85.6K ﹤0.01% 12098
2021
Q1
$232K Buy
59,471
+33,602
+130% +$172K ﹤0.01% 11130
2020
Q4
$130K Sell
25,869
-5,321
-17% -$23.9K ﹤0.01% 10348
2020
Q3
$133K Sell
31,190
-27,776
-47% -$128K ﹤0.01% 9762
2020
Q2
$271K Buy
+58,966
New +$382K ﹤0.01% 8527

Other funds holding IFRX

Susquehanna International Group's IFRX Position: Q1 2026 in Review

Susquehanna International Group increased its InflaRx (IFRX) stake by 96% in Q1 2026, buying an estimated $35.7K and bringing the position to 77,114 shares worth $69K. The position accounts for ﹤0.01% of the portfolio, ranked #12520.

Susquehanna International Group first reported a position in IFRX in Q2 2020 and has held it in 19 quarters since. The position peaked at $795K in Q2 2023. 35 funds tracked by Wall St. Rank hold IFRX as of Q1 2026.

  • Susquehanna International Group held 77,114 shares of InflaRx worth $69K as of Q1 2026.
  • Susquehanna International Group bought 37,741 InflaRx shares in Q1 2026, an estimated $35.7K.
  • InflaRx made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12520 holding.
  • Susquehanna International Group first reported a position in InflaRx in Q2 2020 and has held it in 19 quarters since.
  • Susquehanna International Group's InflaRx position peaked at $795K in Q2 2023.
  • 35 funds tracked by Wall St. Rank held InflaRx as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.